✦ LIBER ✦

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

✍ Scribed by Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

✍ Ulf G. Eriksson; Ulf Bredberg; Kristina Gislén; Linda C. Johansson; Lars Frison; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 291 KB

Antithrombotic and anticoagulant effects

✍ W. WIENEN; J.-M. STASSEN; H. PRIEPKE; U. J. RIES; N. HAUEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Antiinflammatory and antifibrotic effect

✍ Galina S. Bogatkevich; Anna Ludwicka-Bradley; Paul J. Nietert; Tanjina Akter; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

Dose escalating safety study of a new or

✍ B. I. Eriksson; O. E. Dahl; L. Ahnfelt; P. Kälebo; J. Stangier; G. Nehmiz; K. H 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Safety, pharmacodynamics, and pharmacoki

✍ Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 768 KB

Pharmacokinetics and pharmacodynamics of

✍ Hassan Dorani; Kajs-Marie Schützer; Troy C. Sarich; Ulrika Wall; Ulrika Logren; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 601 KB